ReviewFrontiers in immunology2022

Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.

Frédéric Baron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.